Tender ID

Kerala

Cancelled

Goods

Medicines

Re-tender for the procurement of Anti cancer Drugsb for the year 2026-27

Kerala Medical Services Corporation Ltd

Thiruvananthapuram, Kerala

Amount: Refer DocsCloses: 28 Mar 2026Closed

Timeline

Published16 Mar 2026
Cancelled19 Mar 2026

Cancellation Details

Cancellation of Tender

Tender cancellationRe-tenders for the Procurement of Anti Cancer Drugs for the year 2026-27 Cancellation of TenderReason: Due to admistrative reasons/issuesDocument: cancelled_1.pdf

Published 19 Mar 2026

Tender Value

Refer Docs

EMD Value

₹50,000

Closing Date

28 Mar 2026, 5:00 pmClosed

Tender Inviting Organisation

Name

Managing Director

Address

KMSCL, THYCAUD

Work Description

Re-tender for the procurement of Anti cancer Drugsb for the year 2026-27

Tender Information

Tender ID

2026_KMSCL_847813_1

Reference Number

KMSCL/ED/ACD/RT/2026/009

Tender Type

Open Tender

Product Category

Medicines

Form of Contract

Item Wise

Period of Work

365 days

Location

Thiruvananthapuram

Source Website

Subscribe to view

Eligibility / Pre-Qualification

Please refer tender document

Documents Required

22 documents required · 22 mandatory

Fee/PreQual/Technical

RequiredCheck list in Anx 1 (.pdf)

RequiredDocumentry proof that the firm has claimed for exemption from submitting EMD and Tender Cost (.pdf)

RequiredThe details offline EMD submitted as DD/BG (.pdf)

RequiredThe details of Re-inspection fee as per sl no 4 of Anx 1 (.pdf)

RequiredThe details of factory inspection fee as per sl no 5 of Anx 1 (.pdf)

RequiredBid offer form as per sl no 6 of Anx 1 (.pdf)

RequiredBid offer form as per sl no 7 of Anx 1 (.xls)

RequiredNotary attested copy of Annual turnover stmt as per sl no 8 of Anx 1 (.pdf)

RequiredNotary attested copy of valid import license as per sl no 10 of Anx 1 (.pdf)

RequiredNotary attested copies of product wise market standing certificate as per sl no 11 of Anx 1 (.pdf)

RequiredNotary attested copy of valid license for the sale of drugs as per sl no 12 of An x1 (.pdf)

RequiredNotary attested copy of valid WHO-GMP certificate as per sl no 13 of Anx 1 (.pdf)

RequiredNotary attested copy of current Non conviction certificate as per sl no 14 of Anx 1 (.pdf)

RequiredNotary attested performance certificate as per sl no 15 of Anx 1 (.pdf)

RequiredNotary attested copy of Power of Attorney as per sl no 16 of Anx 1 (.pdf)

RequiredNotary attested copy of undertaking as per sl no 18 of Anx 1 (.pdf)

RequiredNotary attested copy of audited balance sheets and P and L stmt as per sl no 19 of Anx 1 (.pdf)

RequiredNotary attested details of echnical personeel as per sl no 20 of Anx 1 (.pdf)

RequiredNotary attested details of the bidder as per sl no 21 of Anx 1 (.pdf)

RequiredNotary attested copy of originalm manufacturing license as per sl no.9 of An x1 (.pdf)

RequiredNotary attested copy of undertaking as per sl no 17 of Anx 1 (.pdf)

Finance

RequiredPrice bid format (.xls)

Fee & Financial Details

Tender Fee Amount

₹29,500

Tender Fee Exemption Allowed

Yes

EMD Fee Amount

₹50,000

EMD Fee Exemption Allowed

Yes

Important Dates

Last Activity

19 Mar 2026

Published

16 Mar 2026

Bid Opening

30 Mar 2026

Download Starts

16 Mar 2026

Download Ends

28 Mar 2026

Submission Starts

16 Mar 2026

Clarification Period

16 Mar 2026 - 28 Mar 2026

BOQ Preview

•

AZATHIOPRINE TAB IP 50 mg

•

CYCLOPHOSPHAMIDE TAB IP 50 mg

•

DACARBAZINE INJ IP/USP 200 mg

•

DACTINOMYCIN INJ 0.5 mg/3 ml

•

DAUNORUBICIN INJ IP 20 mg

•

DEXAMETHASONE TAB IP 8 mg

•

DEXAMETHASONE TAB IP 4 mg

•

ENZALUTAMIDE CAP 80 mg

•

EXEMESTANE TAB IP 25 mg

•

FLUDARABINE PHOSPHATE INJ IP/ USP 50 mg

•

IBANDRONATE TAB 50 mg

•

MEGESTROL ACETATE TAB IP/BP/USP 40 mg

•

MELPHALAN TAB IP 5 mg

•

MERCAPTOPURINE TAB IP 50 mg

•

METHOTREXATE INJ (INTRATHECAL, PRESERVATIVE FREE) 15 mg

•

MITOMYCIN FOR INJ IP/USP 10 mg

•

MITOXANTRONE INFUSION BP/USP 20 mg

•

PROCARBAZINE HCL CAP IP 50 mg

•

RASBURICASE INJ 1.5 mg

•

REGORAFENIB TAB 40 mg

•

RUCAPARIB TAB 300 mg

•

TEGAFUR +URACIL CAP 100 mg + 224 mg

•

VINBLASTINE SULPHATE INJ IP 10 mg

•

VINCRISTINE SULPHATE INJ IP/USP 1 mg

•

CISPLATIN INJ IP 10 mg

•

CISPLATIN INJ IP 50 mg

•

CYCLOPHOSPHAMIDE INJ IP 200 mg

•

CYCLOPHOSPHAMIDE INJ IP 500 mg

•

CYCLOPHOSPHAMIDE INJ IP 1 gm

•

DECITABINE INJ 50 mg

•

DECITABINE INJ 30 mg

•

FLUROURACIL INJ IP 250 mg

•

FLUROURACIL INJ IP 500 mg

•

IFOSFAMIDE WITH MESNA INJ 1 gm

•

IFOSFAMIDE WITH MESNA INJ 2 gm

•

LEUCOVORIN CALCIUM INJ IP 15 mg

•

NILOTINIB CAP 200 mg

•

NILOTINIB CAP 150 mg

Stage Documents

Stage Summary Snapshot

stage.html

html • 0.02 MB

Cancellation Documents

cancelled_1.pdf

pdf • 0.44 MB

Documents

Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.

Tender Page Snapshot

details.html

html • 0.04 MB

NIT Documents

Tendernotice_1.pdf

PDF • 0.42 MB

Work Item Documents

ACD.pdf

Tender Documents • 1.80 MB

BOQ_1432901.xls

BOQ • 0.34 MB

Ready to Participate?

Download all tender documents and submit your bid

Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .

Loading…

Tender ID

Kerala

Cancelled

Goods

Medicines

Re-tender for the procurement of Anti cancer Drugsb for the year 2026-27

Kerala Medical Services Corporation Ltd

Thiruvananthapuram, Kerala

Amount: Refer DocsCloses: 28 Mar 2026Closed

Timeline

Published16 Mar 2026
Cancelled19 Mar 2026